O	0	7	Results	Result	NNS	B-NP

O	8	11	The	The	DT	B-NP
O	12	15	set	set	NN	I-NP
O	16	18	of	of	IN	B-PP
O	19	20	E	E	NN	B-NP
O	20	21	.	.	.	O
O	22	26	coli	coli	NN	B-NP
O	27	37	expression	expression	NN	I-NP
O	38	45	vectors	vector	NNS	I-NP
O	45	46	,	,	,	O
O	47	53	encode	encode	VBP	B-VP
O	54	57	for	for	IN	B-PP
O	58	64	either	either	CC	O
O	65	66	a	a	DT	B-NP
O	67	71	hexa	hexa	NN	I-NP
O	71	72	-	-	HYPH	B-NP
O	72	81	histidine	histidine	NN	I-NP
O	82	85	tag	tag	NN	I-NP
O	86	88	or	or	CC	O
O	89	92	the	the	DT	B-NP
O	93	98	three	three	CD	I-NP
O	99	103	most	most	RBS	I-NP
O	104	112	commonly	commonly	RB	I-NP
O	113	117	used	use	VBN	I-NP
O	118	128	solubility	solubility	NN	I-NP
O	129	133	tags	tag	NNS	I-NP
O	134	135	(	(	(	O
O	135	138	GST	GST	NN	B-NP
O	138	139	,	,	,	O
O	140	143	MBP	MBP	NN	B-NP
O	143	144	,	,	,	O
O	145	149	NusA	NusA	NN	B-NP
O	149	150	)	)	)	O
O	151	154	and	and	CC	O
O	155	158	all	all	DT	B-NP
O	159	163	with	with	IN	B-PP
O	164	166	an	an	DT	B-NP
O	167	168	N	N	NN	I-NP
O	168	169	-	-	HYPH	O
O	169	177	terminal	terminal	JJ	B-NP
O	178	182	hexa	hexa	NN	I-NP
O	182	183	-	-	HYPH	B-NP
O	183	192	histidine	histidine	NN	I-NP
O	193	201	sequence	sequence	NN	I-NP
O	201	202	.	.	.	O

O	203	206	The	The	DT	B-NP
O	207	213	result	result	NN	I-NP
O	214	216	is	be	VBZ	B-VP
O	217	220	two	two	CD	B-NP
O	220	221	-	-	HYPH	I-NP
O	221	225	fold	fold	RB	I-NP
O	225	226	:	:	:	O
O	227	230	the	the	DT	B-NP
O	231	234	His	Hi	NNPS	I-NP
O	234	235	-	-	HYPH	I-NP
O	235	238	tag	tag	NN	I-NP
O	239	250	facilitates	facilitate	VBZ	B-VP
O	251	263	purification	purification	NN	B-NP
O	264	266	by	by	IN	B-PP
O	267	278	immobilised	immobilise	VBN	B-NP
O	279	284	metal	metal	NN	I-NP
O	285	293	affinity	affinity	NN	I-NP
O	294	308	chromatography	chromatography	NN	I-NP
O	308	309	,	,	,	O
O	310	316	whilst	whilst	IN	B-PP
O	317	320	the	the	DT	B-NP
O	321	327	fusion	fusion	NN	I-NP
O	328	335	domains	domain	NNS	I-NP
O	336	339	act	act	VBP	B-VP
O	340	349	primarily	primarily	RB	B-ADVP
O	350	352	as	as	IN	B-PP
O	353	363	solubility	solubility	NN	B-NP
O	364	368	aids	aid	NNS	I-NP
O	369	375	during	during	IN	B-PP
O	376	386	expression	expression	NN	B-NP
O	386	387	,	,	,	O
O	388	390	in	in	IN	B-PP
O	391	399	addition	addition	NN	B-NP
O	400	402	to	to	TO	B-PP
O	403	412	providing	provide	VBG	B-VP
O	413	415	an	an	DT	B-NP
O	416	424	optional	optional	JJ	I-NP
O	425	437	purification	purification	NN	I-NP
O	438	442	step	step	NN	I-NP
O	442	443	.	.	.	O

O	444	446	We	We	PRP	B-NP
O	447	451	have	have	VBP	B-VP
O	452	456	also	also	RB	I-VP
O	457	469	incorporated	incorporate	VBN	I-VP
O	470	471	a	a	DT	B-NP
O	472	475	TEV	TEV	NN	I-NP
O	476	487	recognition	recognition	NN	I-NP
O	488	496	sequence	sequence	NN	I-NP
O	497	506	following	follow	VBG	B-PP
O	507	510	the	the	DT	B-NP
O	511	521	solubility	solubility	NN	I-NP
O	522	525	tag	tag	NN	I-NP
O	526	532	domain	domain	NN	I-NP
O	532	533	,	,	,	O
O	534	539	which	which	WDT	B-NP
O	540	546	allows	allow	VBZ	B-VP
O	547	550	for	for	IN	B-PP
O	551	557	highly	highly	RB	B-NP
O	558	566	specific	specific	JJ	I-NP
O	567	575	cleavage	cleavage	NN	I-NP
O	576	577	(	(	(	O
O	577	582	using	use	VBG	B-VP
O	583	586	TEV	TEV	NN	B-NP
O	587	595	protease	protease	NN	I-NP
O	595	596	)	)	)	O
O	597	599	of	of	IN	B-PP
O	600	603	the	the	DT	B-NP
O	604	610	fusion	fusion	NN	I-NP
O	611	618	protein	protein	NN	I-NP
O	619	621	to	to	TO	B-VP
O	622	627	yield	yield	VB	I-VP
O	628	634	native	native	JJ	B-NP
O	635	642	protein	protein	NN	I-NP
O	642	643	.	.	.	O

O	644	649	These	These	DT	B-NP
O	650	657	vectors	vector	NNS	I-NP
O	658	661	are	be	VBP	B-VP
O	662	666	also	also	RB	I-VP
O	667	675	designed	design	VBN	I-VP
O	676	679	for	for	IN	B-PP
O	680	688	ligation	ligation	NN	B-NP
O	688	689	-	-	HYPH	I-NP
O	689	700	independent	independent	JJ	I-NP
O	701	708	cloning	cloning	NN	I-NP
O	709	712	and	and	CC	O
O	713	717	they	they	PRP	B-NP
O	718	725	possess	possess	VBP	B-VP
O	726	727	a	a	DT	B-NP
O	728	732	high	high	JJ	I-NP
O	732	733	-	-	HYPH	I-NP
O	733	738	level	level	NN	I-NP
O	739	749	expressing	express	VBG	B-VP
O	750	752	T7	T7	NN	B-NP
O	753	761	promoter	promoter	NN	I-NP
O	761	762	,	,	,	O
O	763	768	which	which	WDT	B-NP
O	769	771	is	be	VBZ	B-VP
O	772	780	suitable	suitable	JJ	B-ADJP
O	781	784	for	for	IN	B-PP
O	785	789	auto	auto	AFX	B-NP
O	789	790	-	-	HYPH	I-NP
O	790	799	induction	induction	NN	I-NP
O	799	800	.	.	.	O

O	801	803	To	To	TO	B-VP
O	804	812	validate	validate	VB	I-VP
O	813	816	our	our	PRP$	B-NP
O	817	823	vector	vector	NN	I-NP
O	824	830	system	system	NN	I-NP
O	830	831	,	,	,	O
O	832	834	we	we	PRP	B-NP
O	835	839	have	have	VBP	B-VP
O	840	846	cloned	clone	VBN	I-VP
O	847	851	four	four	CD	B-NP
O	852	861	different	different	JJ	I-NP
O	862	867	genes	gene	NNS	I-NP
O	868	871	and	and	CC	O
O	872	876	also	also	RB	B-ADVP
O	877	880	one	one	CD	B-NP
O	881	885	gene	gene	NN	I-NP
O	886	890	into	into	IN	B-PP
O	891	894	all	all	DT	B-NP
O	895	899	four	four	CD	I-NP
O	900	907	vectors	vector	NNS	I-NP
O	908	911	and	and	CC	O
O	912	916	used	use	VBN	B-VP
O	917	922	small	small	JJ	B-NP
O	922	923	-	-	HYPH	I-NP
O	923	928	scale	scale	NN	I-NP
O	929	939	expression	expression	NN	I-NP
O	940	943	and	and	CC	O
O	944	956	purification	purification	NN	B-NP
O	957	967	techniques	technique	NNS	I-NP
O	967	968	.	.	.	O

O	969	971	We	We	PRP	B-NP
O	972	983	demonstrate	demonstrate	VBP	B-VP
O	984	988	that	that	IN	B-SBAR
O	989	992	the	the	DT	B-NP
O	993	1000	vectors	vector	NNS	I-NP
O	1001	1004	are	be	VBP	B-VP
O	1005	1012	capable	capable	JJ	B-ADJP
O	1013	1015	of	of	IN	B-PP
O	1016	1020	high	high	JJ	B-NP
O	1021	1027	levels	level	NNS	I-NP
O	1028	1030	of	of	IN	B-PP
O	1031	1041	expression	expression	NN	B-NP
O	1042	1045	and	and	CC	O
O	1046	1050	that	that	IN	B-SBAR
O	1051	1060	efficient	efficient	JJ	B-NP
O	1061	1070	screening	screening	NN	I-NP
O	1071	1073	of	of	IN	B-PP
O	1074	1077	new	new	JJ	B-NP
O	1078	1086	proteins	protein	NNS	I-NP
O	1087	1090	can	can	MD	B-VP
O	1091	1093	be	be	VB	I-VP
O	1094	1101	readily	readily	RB	I-VP
O	1102	1110	achieved	achieve	VBN	I-VP
O	1111	1113	at	at	IN	B-PP
O	1114	1117	the	the	DT	B-NP
O	1118	1128	laboratory	laboratory	NN	I-NP
O	1129	1134	level	level	NN	I-NP
O	1134	1135	.	.	.	O

